Concomitant Up-Regulation of Hsa- Mir-374 and Down-Regulation of Its Targets, GSK-3β and APC, in Tissue Samples of Colorectal Cancer
- 1 January 2021
- journal article
- research article
- Published by CMV Verlag in Reports of Biochemistry and Molecular Biology
- Vol. 9 (4), 408-416
- https://doi.org/10.52547/rbmb.9.4.408
Abstract
Background: The WNT-pathway is involved in several cancers, including colorectal cancer (CRC). Many cell signaling components and pathways are controlled by microRNAs. The main purpose of the present study was to investigate the expression of hsa-miR-374, and its two target genes of the Wnt-pathway in CRC clinical samples. Methods: In this study, we predicted the miRNAs targeting key genes of WNT-pathway using bioinformatics algorithms. The expression levels of hsa-miR-374, APC and GSK-3 beta on 48 pairs of Formalin-Fixed Paraffin-Embedded (FFPE) CRC tumors and marginal-tumors were evaluated using real time-PCR. Additionally, the hsa-miR-374a-5p precursor sequence was amplified by whole-blood DNA as a template. This amplicon was cloned into pEGFP-c1 expression vector and transfected into SW742 cells. Aside from this, MTT assay was performed to evaluate the effect of miR-374 on cell viability. Results: The bioinformatics analysis indicated that hsa-miR-374 binds to the regulatory region the key components of WNT-pathway, including APC and GSK-3 beta considering the recognition elements and mirSVR scores. Our results revealed significant down-regulation of GSK-3 beta (0.94 times, p= 0.0098) and APC (0.96 times, p= 0.03) and up-regulation of miR-374 (1.22 times, p= 0.0071) on tumor samples compared with their normal pairs. Meanwhile, the results of the over-expression of miR-374 showed down-regulation of APC and GSK-3 beta. MTT-assay also indicated that the miR-374 increased cell survival. Conclusions: The results of our study indicated a concomitant change in the expression of miR-374 and its two related target genes, in clinical samples of CRC. Hsa-miR-374 might be as a helpful biomarker or therapeutic target in CRC.This publication has 27 references indexed in Scilit:
- Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cellsCarcinogenesis: Integrative Cancer Research, 2013
- MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasisJCI Insight, 2013
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sitesGenome Biology, 2010
- Metastamir: The Field of Metastasis-Regulatory microRNA Is SpreadingCancer Research, 2009
- 1070 Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer ScreeningGastroenterology, 2009
- A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenesOncogene, 2006
- Deregulated GSK3β activity in colorectal cancer: Its association with tumor cell survival and proliferationBiochemical and Biophysical Research Communications, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- Down-regulation of β-Catenin by the Colorectal Tumor Suppressor APC Requires Association with Axin and β-CateninOnline Journal of Public Health Informatics, 2000